More than 38 million Americans suffer from migraine. It is the sixth most disabling neurologic disease globally, according to the World Health Organization.
Yet, migraine often is undiagnosed and left untreated. Dr. Amaal Starling, a neurologist at Mayo Clinic, says because the neurologic disease is so incapacitating, it is important to have a variety of treatment options. Dr. Starling is the lead author of a new study that looked at single pulse transcranial magnetic stimulation for the preventive treatment of migraine.
A migraine. It’s much more than a headache. And it can be debilitating.
“It’s a neurologic disease that has light sensitivity, sound sensitivity, motion sensitivity, nausea, vomiting. There are so many components,” says Dr. Starling.
There is no cure for migraine but there is a new option cleared by the U.S. Food and Drug Administration for the acute and preventive treatment of migraine.
“The device is called a single-pulse transcranial magnetic stimulation device,” says Dr. Starling.
She says the device transmits a signal to the brain, reducing brain hyperexcitability.
“Place it on the back of the head just like that [beeping]’ and then you push these two buttons,” says Dr. Starling. “And that administers a pulse.”
The first step, says Dr. Starling, is to get people with migraine to their health care provider so they can be properly diagnosed and treated.
The Latest on: Migraine
via Google News
The Latest on: Migraine
- Migraine tied to lower diabetes risk in women, study finds on December 18, 2018 at 12:16 pm
French researchers used a cohort of 74,247 women born between 1925 to 1950 and found those with active migraine were at a reduced risk of developing type 2 diabetes during 10 years of follow-up, compa... […]
- Fremanezumab Effective in Patients With Difficult-to-Treat Migraine on December 18, 2018 at 7:48 am
Teva announced topline results from a Phase 3b study evaluating the efficacy and safety of fremanezumab (Ajovy) in adult patients with migraine who previously experienced inadequate responses to 2-4 c... […]
- Teva Reports Positive Top-Line Data for Migraine Candidate on December 18, 2018 at 7:32 am
Teva Pharmaceutical Industries Ltd. TEVA announced positive top-line results from the phase IIIb FOCUS study that evaluated the efficacy and safety of fremanezumab for the preventive treatment of ... […]
- Teva reports positive results for fremanezumab in phase IIIb migraine trial on December 18, 2018 at 2:18 am
Teva Pharmaceutical Industries said that the phase IIIb FOCUS study that evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients has yielded positi... […]
- Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial on December 17, 2018 at 10:47 pm
Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new preventive treatment for Menstrual Migrain... […]
- Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure on December 17, 2018 at 12:48 pm
The hypothesis that migraine headaches may be linked to patent foramen ovale (PFO)—meaning PFO closure could be considered as a treatment—is getting renewed support from two new studies that show prom... […]
- Migraine Tied to Lower Diabetes Risk on December 17, 2018 at 12:39 pm
Women with migraine had a lower risk of developing type 2 diabetes, French researchers reported. In a prospective longitudinal study, women with active migraine had a 20% reduction in the risk of deve... […]
- Migraine may lower risk for type 2 diabetes in women on December 17, 2018 at 8:15 am
Women with active migraine were at lower risk for type 2 diabetes, according to findings recently published in JAMA Neurology. Researchers reviewed questionnaires from 76,403 women (mean age, 61 years ... […]
- How to use exercise to reduce the impact of migraine on December 17, 2018 at 4:43 am
Unfortunately, those who know, know. Migraine can be incredibly debilitating, and worse still, it seems to affect sufferers at random - often at the most unhelpful of times. If you’re living with migr... […]
via Bing News